Showing 1 - 17 results of 17 for search 'Hoskin, P', query time: 0.09s
Refine Results
-
1
Effect of local radiotherapy for bone pain on urinary markers of osteoclast activity. by Hoskin, P, Stratford, MR, Folkes, L, Regan, J, Yarnold, JR
Published 2000Journal article -
2
Influence of plasma glutathione levels on radiation mucositis. by Wardman, P, Folkes, L, Bentzen, S, Stratford, MR, Hoskin, P, Phillips, H, Jackson, S
Published 2001Journal article -
3
-
4
-
5
Effect of nitric-oxide synthesis on tumour blood volume and vascular activity: a phase I study. by Ng, Q, Goh, V, Milner, J, Stratford, MR, Folkes, L, Tozer, G, Saunders, M, Hoskin, P
Published 2007Journal article -
6
A phase II open label, randomised study of ipilimumab with temozolomide versus temozolomide alone after surgery and chemoradiotherapy in patients with recently diagnosed glioblasto... by Brown, NF, Ng, SM, Brooks, C, Blagden, S, Maughan, T, Coutts, T, Holmes, J, Roberts, C, Elhussein, L, Hoskin, P, Mulholland, P
Published 2020Journal article -
7
A gene signature for selecting benefit from hypoxia modification of radiotherapy for high risk bladder cancer patients by Yang, L, Taylor, J, Eustace, A, Irlam, J, Denley, H, Hoskin, P, Alsner, J, Buffa, F, Harris, A, Choudhury, A, West, C
Published 2017Journal article -
8
Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial by Eustace, A, Irlam, J, Taylor, J, Denley, H, Agrawal, S, Choudhury, A, Ryder, D, Ord, J, Harris, A, Rojas, A, Hoskin, P, West, C
Published 2013Journal article -
9
Necrosis predicts benefit from hypoxia-modifying therapy in patients with high risk bladder cancer enrolled in a phase III randomised trial. by Eustace, A, Irlam, J, Taylor, J, Denley, H, Agrawal, S, Choudhury, A, Ryder, D, Ord, J, Harris, A, Rojas, A, Hoskin, P, West, C
Published 2013Journal article -
10
Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia. by Mandeville, H, Ng, Q, Daley, F, Barber, P, Pierce, G, Finch, J, Burke, M, Bell, A, Townsend, E, Kozarski, R, Vojnovic, B, Hoskin, P, Goh, V
Published 2012Journal article -
11
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers. by Harrington, K, Billingham, L, Brunner, T, Burnet, N, Chan, C, Hoskin, P, Mackay, R, Maughan, T, Macdougall, J, Mckenna, W, Nutting, C, Oliver, A, Plummer, R, Stratford, I, Illidge, T
Published 2011Journal article -
12
Radiotherapy research priorities for the UK. by Maughan, T, Illidge, T, Hoskin, P, Mckenna, W, Brunner, T, Stratford, I, Harrington, K, Plummer, R, Billingham, L, Nutting, C, Burnet, N, Mackay, R, Oliver, A, Young, C, Chan, C
Published 2010Journal article -
13
Guidelines for preclinical and early phase clinical assessment of novel radiosensitisers by Harrington, K, Billingham, L, Brunner, T, Burnet, N, Chan, C, Hoskin, P, MacKay, R, Maughan, T, MacDougall, J, Mckenna, W, Nutting, C, Oliver, A, Plummer, R, Stratford, I, Illidge, T
Published 2011Journal article -
14
A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer. by Eustace, A, Mani, N, Span, P, Irlam, J, Taylor, J, Betts, G, Denley, H, Miller, C, Homer, J, Rojas, A, Hoskin, P, Buffa, F, Harris, A, Kaanders, J, West, C
Published 2013Journal article -
15
A restatement of the natural science evidence base concerning the health effects of low-level ionizing radiation by McLean, A, Adlen, E, Cardis, E, Elliott, A, Goodhead, D, Harms-Ringdahl, M, Hendry, J, Hoskin, P, Jeggo, P, Mackay, D, Muirhead, C, Shepherd, J, Shore, R, Thomas, G, Wakeford, R, Godfray, H
Published 2017Journal article -
16
Interim results of a UK NCRI randomised trial comparing involved field radiotherapy with no further treatment after 3 cycles ABVD and a negative PET scan in clinical stages IA/IIA... by Radford, J, Barrington, S, O'Doherty, M, Qian, W, Mouncey, P, Pettengell, R, Hoskin, P, Bessell, E, Coltart, R, Cunningham, D, Culligan, D, Hatton, C, Johnson, P, Kruger, A, Linch, D, Lister, T, Marcus, R, Sadullah, S, Wimperis, J, Hancock, B, Illidge, T, Collaborators, PET
Published 2007Conference item -
17
Development and validation of a 28-gene hypoxia-related prognostic signature for localized prostate cancer by Yang, L, Roberts, D, Takhar, M, Erho, N, Bibby, B, Thiruthaneeswaran, N, Bhandari, V, Cheng, W, Haider, S, McCorry, A, McArt, D, Jain, S, Alshalalfa, M, Ross, A, Schaffer, E, Den, R, Jeffrey Karnes, R, Klein, E, Hoskin, P, Freedland, S, Lamb, A, Neal, D, Buffa, F, Bristow, R, Boutros, P, Davicioni, E, Choudhury, A, West, C
Published 2018Journal article